US Patent 11380854 Heteroleptic iridium complexes as dopants
Patent 11380854 was granted and assigned to Universal Display Corporation on July, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 22 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 22 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113808540
Date of Patent
July 5, 2022
0Patent Application Number
163856370
Date Filed
April 16, 2019
0Patent Citations
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113808540
Date of Patent
July 5, 2022
0Patent Application Number
163856370
Date Filed
April 16, 2019
0Patent Citations
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 6 Jul, 2022
Golden AI
Edits made to:
Infobox (+30 properties)
Article (+263 characters)
US Patent 11380854 Heteroleptic iridium complexes as dopants
Article
Novel phosphorescent heteroleptic iridium complexes with phenylpyridine and dibenzo-containing ligands are provided. Alkyl substitution at specific positions on the ligands gives rise to compounds with improved OLED properties, including saturated green emission.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11380854
Date of patent
July 5, 2022
Patent application number
16385637
Date Filed
April 16, 2019
Patent primary examiner
Find more entities like US Patent 11380854 Heteroleptic iridium complexes as dopants
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
